Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) vs Fiscal Year (FY) 2027 Service Area Competition (SAC)
Side-by-side comparison of two grants.
| Attribute | Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) | Fiscal Year (FY) 2027 Service Area Competition (SAC) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | — | $10.1M |
| Deadline | Closes 2028-01-07 | Closes today |
| Region | US | US |
| Sector | Health | Health |
| Funder | National Institutes of Health | Health Resources and Services Administration |
| Who it's for | researchers, students, government | nonprofits |
noindex — no measured search demand